Cargando…
High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs
(1) Background: High-altitude hypoxia has been shown to affect the pharmacokinetic properties of drugs. Although there is a high incidence of cardiovascular disease among individuals living in high-altitude areas, studies on the effect of high-altitude hypoxia on the pharmacokinetic properties of ca...
Autores principales: | Zhu, Junbo, Duan, Yabin, Duo, Delong, Yang, Jianxin, Bai, Xue, Liu, Guiqin, Wang, Qian, Wang, Xuejun, Qu, Ning, Zhou, Yang, Li, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612038/ https://www.ncbi.nlm.nih.gov/pubmed/36297415 http://dx.doi.org/10.3390/ph15101303 |
Ejemplares similares
-
Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia
por: Bai, Xue, et al.
Publicado: (2022) -
Changes in the Gut Microbiota of Rats in High-Altitude Hypoxic Environments
por: Bai, Xue, et al.
Publicado: (2022) -
Pharmacokinetics of Acetaminophen and Metformin Hydrochloride in Rats After Exposure to Simulated High Altitude Hypoxia
por: Zhu, Jun-bo, et al.
Publicado: (2021) -
The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs
por: Trenaman, Shanna C., et al.
Publicado: (2021) -
Regulation of High-Altitude Hypoxia on the Transcription of CYP450 and UGT1A1 Mediated by PXR and CAR
por: Duan, Ya-bin, et al.
Publicado: (2020)